Automated IV Infusion Compounding With Integrated Volume Control

The patent combines multiple separate components (reconstitution apparatus, infusion apparatus, volume adjustors, valves) into a single integrated device housing. This merging eliminates the need for multiple separate manual operations and reduces the risk of contamination by minimizing the number of times components need to be opened or connected, while maintaining ease of operation through automated coordination of all components.

The integrated device performs multiple functions within a single system: it can reconstitute drugs, control volumes precisely, manage fluid flow through valves, and transfer solutions to infusion bags. This multi-functionality consolidates what would traditionally require multiple separate devices or manual steps into one unified system, reducing complexity while maintaining operational flexibility.

By merging all preparation and delivery components into a single sealed device, the system maintains adaptability for different IV preparations while minimizing contamination risk. The integrated design allows different drugs and formulations to be prepared using the same closed system, eliminating exposure to external contaminants during manual transfers and component connections.

The patent introduces controlled access points (such as sealed ports and valve mechanisms) that act as intermediaries between the internal preparation chambers and the external environment. These controlled interfaces allow adaptability for different preparations while maintaining a protected internal environment that prevents contamination during the preparation and transfer processes.

The integrated device performs self-service automation where the system automatically coordinates the sequence of operations including drug reconstitution, volume adjustment, and solution transfer. The automated valves and pumps eliminate manual handling steps, maintaining operational flexibility for different preparations while dramatically improving productivity by eliminating time-consuming manual operations.

The device is pre-configured with automated sequencing and pre-positioned components that execute preparation steps in the correct order without manual intervention. Volume adjustors and valves are pre-programmed to control fluid flow automatically, allowing the system to maintain operational flexibility while preparing infusions rapidly through predetermined automated actions.

The patent integrates volume control mechanisms directly into the existing apparatus structure, merging the volume adjustors with the reconstitution and infusion chambers. This integration achieves precise volume control through mechanical linkages and controlled valve positions without adding separate complex control systems, maintaining manufacturing precision while minimizing the increase in device complexity.

The patent replaces manual volume adjustment mechanisms with automated mechanical or electromechanical control systems. The volume adjustors utilize controlled mechanical linkages, springs, or electric actuators to precisely control fluid volumes, eliminating manual measurement errors while the integrated design keeps the overall system complexity manageable by using straightforward mechanical principles rather than complex electronic control systems.